Filing Flows

Filing Flows › Inovio Pharmaceuticals (INO) › Next earnings date

Inovio Pharmaceuticals (INO) earnings on Nov 10, 2026: what to expect

Inovio Pharmaceuticals (INO) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.20 (−$0.20 to −$0.19, 2 estimates), against −$0.87 a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 75% chance of beating next time.

Report dateNov 10, 2026
Days to go2
EPS estimate−$0.20
Beat rate75%

The last report

Inovio Pharmaceuticals reported revenue of $65K for the first quarter 2025, net loss $19.7M. How it makes money → · Every quarter →

Inovio Pharmaceuticals: EPS against the estimate, last 4 reportsInovio Pharmaceuticals: EPS against the estimate, last 4 reportsEstimateReported−$0.48−$0.87Nov 25−$0.34−$0.28Mar 26−$0.33−$0.31May 26−$0.24−$0.24Aug 26
Latest (Aug 26): Estimate −$0.24, Reported −$0.24.

Inovio Pharmaceuticals' latest quarter

Inovio Pharmaceuticals, Q1 2025: revenue $65K, net loss $19.7M, operating cash flow −$26.9M. The chart follows the revenue to costs, profit and cash.

Questions

When does INO report earnings?

Inovio Pharmaceuticals is expected to report on Nov 10, 2026.

What are analysts expecting from Inovio Pharmaceuticals?

EPS of −$0.20 for the quarter.

Does Inovio Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.